• NEBANNER

Igiciro cyo Kurushanwa Kuruganda Rwinshi Hagati ya BMK Pmk Ifu 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino] - CAS 22563-90-2

Igiciro cyo Kurushanwa Kuruganda Rwinshi Hagati ya BMK Pmk Ifu 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino] - CAS 22563-90-2

Ibisobanuro bigufi:

URUBANZA no: 376592-93-7

Imiterere yimiti: Intera ya Eltrombopag


Ibicuruzwa birambuye

Ibicuruzwa

"Ubwiza bwa mbere cyane, Kuba inyangamugayo nkibishingiro, gufashanya bivuye ku mutima no kunguka inyungu" nigitekerezo cyacu, mu rwego rwo gushyiraho ubudahwema no gukurikirana indashyikirwa ku giciro cyo guhatanira ibiciro byo guhatanira ibicuruzwa biva mu ruganda hagati ya BMK Pmk Powder 1-Propanol, 2-Methyl-2- [.Kubona ni Kwizera, ushaka amakuru menshi?Gerageza gusa kubintu byayo!
"Ubwiza bwa mbere cyane, Kuba inyangamugayo nkibishingiro, ubufasha buvuye ku mutima no kunguka inyungu" nigitekerezo cyacu, mu rwego rwo gushiraho ubudahwema no gukurikirana indashyikirwa kuriUbushinwa bwa Farumasi n’ubuhinzi n’ubuhinzi, Kugirango ubone ibisobanuro byinshi kuri twe kimwe no kubona ibicuruzwa byacu byose, nyamuneka sura urubuga.Kugirango ubone ibisobanuro byinshi nyamuneka wumve neza kutwemerera.Urakoze cyane kandi wifurije ubucuruzi bwawe guhora ari bwiza!

3′-Amino-2′-hydroxy- [1,1'-bipheny] -3-karubasi ya acide ikoreshwa nka interineti ya Eltrombopag.
Eltrombopag, yakozwe na GlaxoSmithKline (GSK) mu Bwongereza nyuma iza gukorana na Novartis mu Busuwisi, ni yo ya mbere kandi yemewe ya molekile ntoya itari peptide TPO yakira agonist ku isi.Eltrombopag yemejwe na FDA yo muri Amerika muri 2008 kugirango ivure idiopathic trombocytopenic purpura (ITP), naho muri 2014 yo kuvura anemia ikabije (AA).Ninumuti wambere wemejwe na FDA yo muri Amerika kuvura AA mumyaka 30 ishize.
Ukuboza2012, FDA yo muri Amerika yemeye Eltrombopag kuvura trombocytopenia ku barwayi barwaye hepatite C idakira (CHC), ku buryo abarwayi ba hepatite C bafite uburwayi buke buterwa na platine nkeya bashobora gutangira kandi bagakomeza kuvura bisanzwe bishingiye ku ndwara z’umwijima.Ku ya 3 Gashyantare 2014, GlaxoSmithKline yatangaje ko FDA yatanze impamyabumenyi y’ubuvuzi ya Eltrombopag yo kuvura indwara ya hémopenia ku barwayi bafite imiti ikaze y’imiti idakira (SAA) ititabira byimazeyo ubudahangarwa bw'umubiri.Ku ya 24 Kanama 2015, FDA yo muri Amerika yemeje Eltrombopag kuvura trombocytopenia ku bantu bakuru ndetse n’abana bafite imyaka 1 n’imyaka irenga hamwe na immunite trombocytopenia idakira (ITP) badafite ibisubizo bidahagije kuri corticosteroide, immunoglobuline cyangwa splenectomy.Ku ya 4 Mutarama 2018, Eltrombopag yemerewe gushyirwa ku rutonde mu Bushinwa kugira ngo ivurwe mbere na mbere na trombocytopenia (ITP).

"Ubwiza bwa mbere cyane, Kuba inyangamugayo nkibishingiro, gufashanya bivuye ku mutima no kunguka inyungu" nigitekerezo cyacu, mu rwego rwo gushyiraho ubudahwema no gukurikirana indashyikirwa ku giciro cyo guhatanira ibiciro byo guhatanira ibicuruzwa biva mu ruganda hagati ya BMK Pmk Powder 1-Propanol, 2-Methyl-2- [.Kubona ni Kwizera, ushaka amakuru menshi?Gerageza gusa kubintu byayo!
Igiciro cyo Kurushanwa kuriUbushinwa bwa Farumasi n’ubuhinzi n’ubuhinzi, Kugirango ubone ibisobanuro byinshi kuri twe kimwe no kubona ibicuruzwa byacu byose, nyamuneka sura urubuga.Kugirango ubone ibisobanuro byinshi nyamuneka wumve neza kutwemerera.Urakoze cyane kandi wifurije ubucuruzi bwawe guhora ari bwiza!


  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze